Sign In

25.37 : Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Efforts have been made to enhance the initial immune response with the goal of completely eliminating early-stage cancer and thus preventing escape. Promising methods such as cancer vaccines are under development. These vaccines aim to boost a person's anti-cancer immune response by introducing treated cancer cells into patients, leading to extended survival rates. The malignant melanoma and renal cell carcinoma vaccines have already shown positive results in clinical trials.

Despite its complexities, the immune system provides benefits that far outweigh its occasional failures. Cancer immunotherapeutics, which focuses on using immune responses to diagnose, monitor, and treat cancer, has become a focal point in research due to the often inadequate protection provided by immunity, as reflected by the yearly cancer mortality rate.

Immunotherapy plays a key role in the fight against cancer by helping the immune system act more effectively. Several types of immunotherapy exist, including immune checkpoint inhibitors, T-cell transfer therapy, monoclonal antibodies, treatment vaccines, and immune system modulators.

Immunotherapy has been approved for treating many types of cancer, but it is not yet as widely used as other treatments such as surgery, chemotherapy, or radiation therapy. Immunotherapy can be administered in different ways, including intravenous, oral, topical, and intravesical. The frequency and duration of treatment depend on several factors, including the type of cancer, its stage, the type of immunotherapy, and the patient's reaction to the treatment. Regular check-ups and medical tests are essential to measuring the effectiveness of immunotherapy.

Tags
Tumor ImmunotherapyImmune SystemCancer TreatmentImmune ResponseCancer VaccinesMalignant MelanomaRenal Cell CarcinomaCancer ImmunotherapeuticsImmune Checkpoint InhibitorsT cell Transfer TherapyMonoclonal AntibodiesTreatment VaccinesImmune System ModulatorsCancer Mortality RateTreatment Administration Methods

From Chapter 25:

article

Now Playing

25.37 : Tumor Immunotherapy

The Lymphatic and Immune System

151 Views

article

25.1 : Introduction to Lymphatic and Immune System

The Lymphatic and Immune System

833 Views

article

25.2 : Functions of the Lymphatic and Immune System

The Lymphatic and Immune System

422 Views

article

25.3 : Lymphatic Vessels and Lymph Transport

The Lymphatic and Immune System

409 Views

article

25.4 : Lymphoid Cells and Tissues

The Lymphatic and Immune System

316 Views

article

25.5 : Primary Lymphoid Organs

The Lymphatic and Immune System

434 Views

article

25.6 : Secondary Lymphoid Organs

The Lymphatic and Immune System

359 Views

article

25.7 : Detailed Structure and Function of Lymph Nodes

The Lymphatic and Immune System

325 Views

article

25.8 : Development of the Lymphatic System

The Lymphatic and Immune System

135 Views

article

25.9 : Introduction to Innate and Adaptive Immunity

The Lymphatic and Immune System

1.4K Views

article

25.10 : Surface Membrane Barriers

The Lymphatic and Immune System

226 Views

article

25.11 : Cells of the Innate Immune Response

The Lymphatic and Immune System

392 Views

article

25.12 : Antimicrobial Proteins

The Lymphatic and Immune System

212 Views

article

25.13 : Complement System

The Lymphatic and Immune System

532 Views

article

25.14 : Immune Surveillance by NK Cells and Phagocytes

The Lymphatic and Immune System

325 Views

See More

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved